SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-023145
Filing Date
2022-06-15
Accepted
2022-06-15 21:07:08
Documents
2
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3647
2 EXHIBIT 24 brhc10038816_ex24.htm EX-24 9949
  Complete submission text file 0001140361-22-023145.txt   15095
Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
BOESS CARSTEN (Reporting) CIK: 0001277495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 221019212

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations